Back to Search
MARK OGLETREE, M.A., PH.D., L.P.C.
M.A., PH.D., L.P.C.
Mental Health Counselor
NPI: 1902004237Individual
Specialties, Licenses & Credentials
Mental Health CounselorPrimary
Counselor — Mental Health
Code: 101YM0800X
19816(TX)
Research & Publications (17)
Effects of remifentanil on the contractility of failing human heart muscle.
PMID 16326302·J Cardiothorac Vasc Anesth·2005
8-other
Prediction of the therapeutic index of marketed anti-coagulants and anti-platelet agents by guinea pig models of thrombosis and hemostasis.
PMID 18479740·Thromb Res·2008
7-preclinical
Antithrombotic and hemostatic effects of a small molecule factor XIa inhibitor in rats.
PMID 17597608·Eur J Pharmacol·2007
7-preclinical
Spontaneous atherothrombosis and medial degradation in Apoe-/-, Npc1-/- mice.
PMID 17984379·Circulation·2007
4-observational
Platelet aggregometry and receptor binding to predict the magnitude of antithrombotic and bleeding time effects of clopidogrel in rabbits.
PMID 17513951·J Cardiovasc Pharmacol·2007
4-observational
Biomarker optimization to track the antithrombotic and hemostatic effects of clopidogrel in rats.
PMID 17420297·J Pharmacol Exp Ther·2007
7-preclinical
Effects of factor XI deficiency on ferric chloride-induced vena cava thrombosis in mice.
PMID 16961605·J Thromb Haemost·2006
7-preclinical
Murine model of ferric chloride-induced vena cava thrombosis: evidence for effect of potato carboxypeptidase inhibitor.
PMID 16420573·J Thromb Haemost·2006
7-preclinical
Effects of factor IX or factor XI deficiency on ferric chloride-induced carotid artery occlusion in mice.
PMID 15733058·J Thromb Haemost·2005
7-preclinical
Solid-phase synthesis and SAR of 4-carboxy-2-azetidinone mechanism-based tryptase inhibitors.
PMID 15081015·Bioorg Med Chem Lett·2004
8-other
Synthesis of potent and highly selective nonguanidine azetidinone inhibitors of human tryptase.
PMID 15081014·Bioorg Med Chem Lett·2004
8-other
Inhibition of tumor necrosis factor-alpha-converting enzyme by a selective antagonist protects brain from focal ischemic injury in rats.
PMID 15044618·Mol Pharmacol·2004
7-preclinical
Molecular design and structure--activity relationships leading to the potent, selective, and orally active thrombin active site inhibitor BMS-189664.
PMID 11738570·Bioorg Med Chem Lett·2002
7-preclinical
Synthesis and SAR of 4-carboxy-2-azetidinone mechanism-based tryptase inhibitors.
PMID 12372540·Bioorg Med Chem Lett·2002
7-preclinical
Thrombin active site inhibitors: chemical synthesis, in vitro and in vivo pharmacological profile of a novel and selective agent BMS-189090 and analogues.
PMID 11738569·Bioorg Med Chem Lett·2002
7-preclinical
Retro-binding thrombin active site inhibitors: identification of an orally active inhibitor of thrombin catalytic activity.
PMID 12372529·Bioorg Med Chem Lett·2002
7-preclinical
Synthesis of potent and highly selective inhibitors of human tryptase.
PMID 12372541·Bioorg Med Chem Lett·2002
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 4829 CEDAR CREST DR
MCKINNEY, TX 75070 - Phone
- (972) 569-8176
Quick Facts
- NPI
- 1902004237
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 17
Are you this provider?
Claim Your Profile